These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36655200)

  • 1. B-Cell Responses to Sars-Cov-2 mRNA Vaccines.
    Kardava L; Buckner CM; Moir S
    Pathog Immun; 2022; 7(2):93-119. PubMed ID: 36655200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond.
    Bettini E; Locci M
    Vaccines (Basel); 2021 Feb; 9(2):. PubMed ID: 33673048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines.
    Pape KA; Dileepan T; Kabage AJ; Kozysa D; Batres R; Evert C; Matson M; Lopez S; Krueger PD; Graiziger C; Vaughn BP; Shmidt E; Rhein J; Schacker TW; Khoruts A; Jenkins MK
    Cell Rep; 2021 Oct; 37(2):109823. PubMed ID: 34610291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
    Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
    Front Immunol; 2021; 12():726960. PubMed ID: 34671348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into human immune memory from SARS-CoV-2 infection and vaccination.
    Hartley GE; Edwards ESJ; O'Hehir RE; van Zelm MC
    Allergy; 2022 Dec; 77(12):3553-3566. PubMed ID: 36048132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA COVID-19 Vaccines and Long-Lived Plasma Cells: A Complicated Relationship.
    Giannotta G; Giannotta N
    Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior SARS-CoV-2 Infection Enhances Initial mRNA Vaccine Response with a Lower Impact on Long-Term Immunity.
    Silva-Moraes V; Souquette A; Sautto GA; Paciello I; Antonelli G; Andreano E; Rappuoli R; Teixeira-Carvalho A; Ross TM
    Immunohorizons; 2023 Oct; 7(10):635-651. PubMed ID: 37819998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines.
    Sette A; Crotty S
    Immunol Rev; 2022 Sep; 310(1):27-46. PubMed ID: 35733376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation.
    Lederer K; Castaño D; Gómez Atria D; Oguin TH; Wang S; Manzoni TB; Muramatsu H; Hogan MJ; Amanat F; Cherubin P; Lundgreen KA; Tam YK; Fan SHY; Eisenlohr LC; Maillard I; Weissman D; Bates P; Krammer F; Sempowski GD; Pardi N; Locci M
    Immunity; 2020 Dec; 53(6):1281-1295.e5. PubMed ID: 33296685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population.
    Bednarski E; Del Rio Estrada PM; DaSilva J; Boukadida C; Zhang F; Luna-Villalobos YA; Rodríguez-Rangel X; Pitén-Isidro E; Luna-García E; Díaz Rivera D; López-Sánchez DM; Tapia-Trejo D; Soto-Nava M; Astorga-Castañeda M; Martínez-Moreno JO; Urbina-Granados GS; Jiménez-Jacinto JA; Serna Alvarado FJ; Enriquez-López YE; López-Arellano O; Reyes-Teran G; Bieniasz PD; Avila-Rios S; Hatziioannou T
    mBio; 2022 Aug; 13(4):e0084022. PubMed ID: 35735743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon
    Byazrova MG; Kulemzin SV; Astakhova EA; Belovezhets TN; Efimov GA; Chikaev AN; Kolotygin IO; Gorchakov AA; Taranin AV; Filatov AV
    Front Immunol; 2022; 13():840707. PubMed ID: 35280987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV.
    Verburgh ML; van Pul L; Grobben M; Boyd A; Wit FWNM; van Nuenen AC; van Dort KA; Tejjani K; van Rijswijk J; Bakker M; van der Hoek L; Schim van der Loeff MF; van der Valk M; van Gils MJ; Kootstra NA; Reiss P
    Microbiol Spectr; 2023 Jun; 11(3):e0115523. PubMed ID: 37166335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
    Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G
    mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to SARS-CoV-2 induced by infection or vaccination.
    Castro Dopico X; Ols S; Loré K; Karlsson Hedestam GB
    J Intern Med; 2022 Jan; 291(1):32-50. PubMed ID: 34352148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines.
    Al-Sheboul SA; Brown B; Shboul Y; Fricke I; Imarogbe C; Alzoubi KH
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination.
    Taus E; Hofmann C; Ibarrondo FJ; Gong LS; Hausner MA; Fulcher JA; Krogstad P; Kitchen SG; Ferbas KG; Tobin NH; Rimoin AW; Aldrovandi GM; Yang OO
    Front Immunol; 2023; 14():1100594. PubMed ID: 36860850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.
    Fiorino F; Ciabattini A; Sicuranza A; Pastore G; Santoni A; Simoncelli M; Polvere J; Galimberti S; Baratè C; Sammartano V; Montagnani F; Bocchia M; Medaglini D
    Front Immunol; 2022; 13():1017863. PubMed ID: 36248803
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.